期刊
DIABETES & METABOLISM JOURNAL
卷 45, 期 6, 页码 799-812出版社
KOREAN DIABETES ASSOC
DOI: 10.4093/dmj.2021.0077
关键词
Adipokines; Adipose tissue; Neoplasms; Diabetes mellitus; type 2; Hyperlipidemia; Insulin resistance; Obesity
资金
- US National Institutes of Health [R01-DK55758, R01-DK-127274, R01-DK099110, RC2-DK118620, P01-AG051459]
High rates of obesity and diabetes are associated with increased risk of multiple types of cancers, influenced by various factors. Metabolic abnormalities caused by obesity and diabetes may significantly contribute to the development and progression of cancer through the regulation of distinct signaling pathways.
Rates of obesity and diabetes have increased significantly over the past decades and the prevalence is expected to continue to rise further in the coming years. Many observations suggest that obesity and diabetes are associated with an increased risk of developing several types of cancers, including liver, pancreatic, endometrial, colorectal, and post-menopausal breast cancer. The path towards developing obesity and diabetes is affected by multiple factors, including adipokines, inflammatory cytokines, growth hormones, insulin resistance, and hyperlipidemia. The metabolic abnormalities associated with changes in the levels of these factors in obesity and diabetes have the potential to significantly contribute to the development and progression of cancer through the regulation of distinct signaling pathways. Here, we highlight the cellular and molecular pathways that constitute the links between obesity, diabetes, cancer risk and mortality. This includes a description of the existing evidence supporting the obesity-driven morphological and functional alternations of cancer cells and adipocytes through complex interactions within the tumor micro environment.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据